Pre-earnings options volume in Zevra Therapeutics (ZVRA) Inc is 2.4x normal with calls leading puts 3:1. Implied volatility suggests the market is anticipating a move near 12.4%, or $1.46, after results are released. Median move over the past eight quarters is 3.3%.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZVRA:
- ZVRA Earnings this Week: How Will it Perform?
- Zevra Therapeutics’ Strategic Advancements and Market Potential Drive Buy Rating
- Zevra Therapeutics: Buy Rating Affirmed on European Market Expansion and Growth Potential
- Zevra Therapeutics submits MAA to EMA for evaluation of arimoclomol
- Zevra Therapeutics announces MIPLYFFA , OLPRUVA presentations at SERGG